Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-366-1 | CAS number: 106-14-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- From Apr. 1988 to Jul. 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to accepted guidelines in compliance with GLP.
- Justification for data waiving:
- other:
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Principles of method if other than guideline:
- The core study was conducted with groups of 10 rats and 10 mice per sex, each group receiving diets containing castor oil at various doses, continuously for 13 wk. Ten additional rats/sex were included at each dose level for evaluation of hematological and clinical chemistry parameters.
At the study termination, all core-study animals were euthanized by CO2 anesthesia, and complete necropsies were performed.
To screen for potential reproductive toxicity, sperm motility and morphology were evaluated at necropsy, and vaginal cytology was evaluated on core-study animals during the wk just preceding necropsy, following published procedures (Morrissey et al., 1988). For the 12 d prior to termination, females were subject to vaginal lavage with saline. The relative preponderance of leukocytes, nucleated epithelial cells, and large squamous epithelial cells were used to identify the stages of the estrual cycle.
Sperm motility was evaluated at necropsy and was presented as spermatid heads per total testis and per gram of testis. - GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Castor oil
- EC Number:
- 232-293-8
- EC Name:
- Castor oil
- Cas Number:
- 8001-79-4
- IUPAC Name:
- Castor oil
- Details on test material:
- - Name of test material (as cited in study report): Castor oil
- Analytical purity: purity and analyses were conducted by Midwest Research Institute (MRI) (Kansas City, MO). MRI reports on the analyses performed in support of the castor oil studies are on file at the National Institute of Environmental Health Sciences (research triangle park, NC)
- Composition of test material, percentage of components: 87% ricinoleic, 7% oleic, 3% linoleic, 2% palmitic, 1% stearic and trace amounts of dihydroxystearic.
- Lot/batch No.: L-5G30-01
- Stability under test conditions: Monitored by determination of peroxide content and by HPLC. No deterioration of the castor oil study material was observed over the course of the study.
- Other: Obtained from Cas Chemical Inc. (Bayonne, NJ)
Constituent 1
Test animals
- Species:
- other: rat and mouse
- Strain:
- other: F344/N rats and B6C3F1 mice
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Simonsen Laboratories (Gilroy, CA)
- Age at study initiation: 6 wk
- Weight at study initiation:
Males (rat): 126-132 g
Females (rat): 107-110 g
Males (mouse): 22.6-23.0 g
Female (mouse): 17.2-17.7 g
- Fasting period before study: No
- Housing:
Rat: The rats were housed 5 per cage. Polycarbonate cages lined with heat-treated hardwood chips and covered with polyester filter sheets were used.
Mouse: The mice were housed individually. Polycarbonate cages lined with heat-treated hardwood chips and covered with polyester filter sheets were used.
- Diet (e.g. ad libitum): Ad libitum; feeders were changed twice per wk throughout the study
- Water (e.g. ad libitum): The cages were stored on stainless steel racks equipped with an automatic watering system.
- Acclimation period:
Rat: 14 d
Mouse: 15 d
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.3 (68-76°F)
- Humidity (%):42-72 %
- Air changes (per hr): 10 times/h. Incoming air was filtered to remove particulates
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE, AGE: From: 16 wk To: 19 wk
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
DIET PREPARATION
- Rate of preparation of diet (frequency): 2/wk - Details on mating procedure:
- Not applicable
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Periodic analysis of the castor oil-formulated diets was conducted by HPLC at the study and analytical chemistry laboratories. Three complete sets of formulated diet mixtures were analyzed. All but a single sample were within specifications (±10% of the target concentration). A single low-dose mixture which did not meet specifications was remixed and found to be within specifications before it was given to the animals. The results of the analyses for all dose mixtures given to the animals ranged from 97 to 106% of the target concentrations.
- Duration of treatment / exposure:
- 13 wk
- Frequency of treatment:
- Daily
- Details on study schedule:
- Not applicable
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 0.62, 1.25, 2.5, 5.0 or 10% in diet
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- None
- Positive control:
- None
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
DETAILED CLINICAL OBSERVATIONS: Yes
BODY WEIGHT: Yes
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes - Oestrous cyclicity (parental animals):
- The relative preponderance of leukocytes, nucleated epithelial cells, and large squamous epithelial cells were used to identify the stages of the estrual cycle.
- Sperm parameters (parental animals):
- Parameters examined in all male parental generations:
- Sperm morphology.
- Sperm motility which was evaluated at necropsy as follows: The left epididymis was removed and weighed; the cauda epididymis was removed at the junction of the vas deferens and the corpus epididymis, then weighed. The sperm that were removed from the epididymis were dispersed and the number of moving and non-moving sperms were counted in 5 fields of 30 sperm or less on each slide. Sperm density was then determined using a hemocytometer.
Homogenization spermatid nuclei were enumerated using a hemocytometer; the data were expressed as spermatid heads per total testis and per gram of testis. - Postmortem examinations (parental animals):
- GROSS NECROPSY
- A complete necropsy was conducted
HISTOPATHOLOGY / ORGAN WEIGHTS
Organ weights: Liver, right kidney, right testicle, heart, thymus, and lungs
The following tissues were routinely processed for preparation of histologic sections and microscopic examination: Adrenal glands, brain, cecum, colon, duodenum, epididymis/seminal vesicles/prostate/testes or ovaries/uterus, esophagus, eyes (if grossly abnormal), femur (including marrow), heart, ileum, jejunum, kidneys, liver, lungs and mainstem bronchi, mammary gland, mandibular and mesenteric lymph nodes, nasal cavity and turbinates, pancreas, parathyroid glands, pituitary gland, preputial or clitoral glands, rectum, salivary glands, skin, spinal cord and sciatic nerve (if neurologic signs present), spleen, fore-stomach and glandular stomach, thymus, thyroid gland, trachea, urinary bladder, zymbal glands, and all gross lesions and tissue masses including regional lymph nodes. A complete histopathologic examination was conducted on all rats and mice from the control and the 9.67 ± 0.54 mg/L dose groups. Liver was examined from male rats in all other dose groups, and histologic sections of gross lesions were examined from all rats. - Statistics:
- Body weight and organ weight data were statistically analyzed within each sex by one-way analysis of variance tests, followed by Dunnett's t-test if pair-wise comparisons were indicated (p < 0.05)(Dunnett, 1955).
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Other effects:
- effects observed, treatment-related
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- not examined
Details on results (P0)
Rat: No clinical signs or mortality were observed in the groupe tested at any dose level.
Mouse: No clinical signs or mortality were observed in the group tested at any dose level.
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS):
- Rat, male: Mean body weights of rats receiving diets containing castor oil did not differ significantly from controls
- Rat, female: Mean body weights of exposed female rats were slightly lower than the mean body weights of controls but the differences were not dose-related.
- Mouse, male: There were no statistically significant differences in average food consumption among groups. The mean body weights of exposed male mice generally were lower than controls.
- Mouse, female: Female mice receiving diets containing 9.67 mg/L bw was slightly lower than controls.
Mean body weights of exposed females generally were higher than the controls.
REPRODUCTIVE FUNCTION: ESTROUS CYCLE (PARENTAL ANIMALS):
Rat: No effects observed at any dose level
Mouse: No effects observed at any dose level
REPRODUCTIVE FUNCTION: (PARENTAL ANIMALS):
- Rat, male: There was a slight decrease in epididymal weight (6-7%) which occurred in the middle- and high-dose groups, but this was not dose-related. There was some variation in epididymal weights, however, their small magnitude and the absence of changes in other endpoints suggested that there was little or no evidence of any reproductive toxicity associated with castor oil exposure.
- Mouse, male: No was no adverse effects on any male at any dose level. The low value for sperm motility in control mice was attributed to poor preparative technique.
ORGAN WEIGHTS (PARENTAL ANIMALS):
- Rat, male: Absolute liver weights and the liver-to-body-weight ratio were increased in male rats that received diets containing the highest dose of castor oil. Heart-to-body-weight ratios were increased in groups of male rats receiving 0.62, 2.64 and 9.67 mg/L bw diets; however, absolute heart weights were not increased, and the differences in body weight ratios were small and not considered treatment related. Using light microscopy, it was determined that there were no morphologic changes associated with the slight differences in organ weights between groups.
- Rat, female: No effects reported.
- Mouse, male: Liver weights were increased in male mice that received diets containing 4.91 or 9.67 mg/L castor oil.
- Mouse, female: Liver weights were increased in female mice that received diets containing 4.91 or 9.67 mg/L castor oil. Kidney weights were increased in female mice that received 4.91 or 9.67 mg/L diets. Using light microscopy, it was determined that there were no morphologic changes associated with the slight differences between groups in organ weights.
HISTOPATHOLOGY (PARENTAL ANIMALS):
- Rat: Histopathologic examination revealed an absence of compound-related lesions in any organ or tissue of rats exposed to castor oil in the diet.
- Mouse: Histopathologic examination revealed an absence of compound-related lesions in any organs or tissues of mice exposed to castor oil in the diet.
OTHER FINDINGS (PARENTAL ANIMALS):
- Rat: Hematological effects of the castor oil diets among male rats included a slight decrease in MCHC at Day 21 in those receiving the 9.67 mg/L diet; a statistically significant decrease in MCV among the 9.67 mg/L group; a decrease in MCH among the 4.91 mg/L and 9.67 mg/L groups; and an increase in platelets among the 1.26 mg/L, 4.91 mg/L, and 9.67 mg/L groups. The only change observed among female rats was a statistically significant decrease in reticulocyte counts at Day 5 in groups receiving the 0.62 mg/L or 9.67 mg/L diets. None of these changes was considered biologically significant. A treatment- and dose-related increase in the activity of serum alkaline phosphatase was observed in male and female rats at Day 5 and 21, and at study termination. Total bile acids
16NTP TOX 12, castor oil were increased among males receiving the higher dietary levels at Day 5 and 21 but were not increased at study termination. Other minor changes included increases in albumin observed at study termination in males receiving 4.91 mg/L diets and at Day 5 in females receiving 9.67 mg/L diets, and an increase in urea nitrogen at study termination in males that received 0.62 mg/L diets and a decrease at Day 5 in females that received castor oil at 9.67 mg/L in the diet.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOAEC
- Effect level:
- >= 9.13 - <= 10.21 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Rat. Effect level based on reproductive parameters
- Dose descriptor:
- NOAEC
- Effect level:
- >= 9.13 - <= 10.21 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Mouse. Effect level based on reproductive parameters
Results: F1 generation
Details on results (F1)
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- Under the test conditions, a reproductive NOAEC value for male/female rats and mice was determined to be 10% (i.e., ca. 5,000 mg/kg bw/day in rats and 13,000 mg/kg bw/day in mice), after 13 weeks of exposure to castor oil.
- Executive summary:
A 13 week study was conducted according to a method equivalent/similar to OECD Guideline 422 to evaluate the reproductive toxicity effects on mice and rats fed with castor oil.
The core study was conducted with groups of 10 rats and 10 mice per sex, each group receiving diets containing test substance at various doses, continuously for 13 weeks. Ten additional rats/sex were included at each dose level for evaluation of hematological and clinical chemistry parameters. At termination, all core-study animals were euthanized by CO2 anesthesia, and complete necropsies were performed. To screen for potential reproductive toxicity, sperm motility and morphology were evaluated at necropsy, and vaginal cytology was evaluated on core-study animals during the week just preceding necropsy. For the 12 d prior to termination, females were subject to vaginal lavage with saline solution. The relative preponderance of leukocytes, nucleated epithelial cells and large squamous epithelial cells were used to identify the stages of the estrual cycle. Sperm motility was evaluated at necropsy and was presented as spermatid heads per total testis and per gram of testis.
Exposure to test substance at dietary concentrations as high as 9.67 mg/L did not affect survival or body weight gains of rats or mice. There were no biologically significant effects noted in hematologic analyses in rats. Mild increases in total bile acids and in serum alkaline phosphatase were noted at various times during the studies in rats receiving the higher dietary concentrations of the test substance. Liver weights were increased in male rats receiving the 10% dietary concentration and in male and female mice receiving diets containing 4.91 or 9.67 mg/L test substance. However, there were no histopathologic lesions associated with these liver changes, nor were there any compound-related morphologic changes in any organ in rats or mice. No significant changes were noted in a screening for male reproductive endpoints, including sperm count and motility, and no changes were observed in the length of estrous cycles of rats or mice given diets containing the test substance. Thus, no significant adverse effects of the test substance administration were noted in these studies.
Under the test conditions, a reproductive NOAEC value for male/female rats and mice was determined to be 10% (i.e., ca. 5,000 mg/kg bw/day in rats and 13,000 mg/kg bw/day in mice), after 13 weeks of exposure to castor oil.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.